Adam S. Mostafa
2022
In 2022, Adam S. Mostafa earned a total compensation of $1.9M as Chief Financial Officer, Treasurer and Secretary at X4 Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Bonus | $46,085 |
|---|---|
| Non-Equity Incentive Plan | $193,555 |
| Option Awards | $954,900 |
| Salary | $458,973 |
| Stock Awards | $226,800 |
| Other | $569 |
| Total | $1,880,882 |
Mostafa received $954.9K in option awards, accounting for 51% of the total pay in 2022.
Mostafa also received $46.1K in bonus, $193.6K in non-equity incentive plan, $459K in salary, $226.8K in stock awards and $569 in other compensation.
Rankings
In 2022, Adam S. Mostafa's compensation ranked 1,864th out of 5,760 executives tracked by ExecPay. In other words, Mostafa earned more than 67.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,864 out of 5,760 | 68th |
Division Manufacturing | 980 out of 3,136 | 69th |
Major group Chemicals And Allied Products | 406 out of 1,422 | 71st |
Industry group Drugs | 371 out of 1,323 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 93 out of 291 | 68th |
Source: SEC filing on April 25, 2023.
Mostafa's colleagues
We found two more compensation records of executives who worked with Adam S. Mostafa at X4 Pharmaceuticals in 2022.
News
X4 Pharmaceuticals CEO Paula Ragan's 2022 pay jumps 81% to $3.9M
April 25, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021
X4 Pharmaceuticals CEO Paula Ragan's 2019 pay jumps 171% to $2.5M
April 28, 2020
X4 Pharmaceuticals CEO René BCPS' 2018 pay jumps 188% to $3.4M
May 22, 2019